Enlarge / Moderna CEO Stephane Bancel during a Bloomberg Television interview on the closing day of the World Economic Forum in Davos, Switzerland, on May 26, 2022. (credit: Getty | Jason Alden)
The CEOs of more than 300 publicly traded health care companies collectively raked in $4 billion last year as Americans struggled under high inflation, according to an analysis by Stat News.
Topping the income chart is the CEO of Moderna, the company that developed one of the leading COVID-19 vaccines in the world—with significant support from US taxpayers and federal scientists.
Moderna's Stéphane Bancel made $398 million in 2022, which equaled the total pay for the next six highest-paid CEOs in the biotech and pharma sector, according to Stat's analysis. It also put Bancel near the top of the income inequality chart, showing Bancel's compensation was 2,435 times more than the median salary of Moderna employees last year.
Read 6 remaining paragraphs | Comments
Ars Technica - All contentContinue reading/original-link]
